Case report reveals hyperhemolysis syndrome impacting hemoglobin levels in a delta-beta thalassemia patient, suggesting the role of macrophage activation.
Key Points
The patient experienced a paradoxical drop in hemoglobin levels post-transfusion, indicative of hyperhaemolysis syndrome.
Management included intravenous immunoglobulin and corticosteroids, resulting in initial improvement of hemoglobin levels.
Macrophage activation syndrome was suspected due to persistent symptoms, leading to further treatment adjustments.
Early recognition of hyperhaemolysis syndrome in patients with hemoglobinopathies is crucial for timely immunotherapy.